Tag archief: English Only

Lightpoint Medical Secures £5 Million for Product Commercialization

CHESHAM, England–(BUSINESS WIRE)– Lightpoint Medical, a leader in intraoperative molecular imaging and sensing, announced today that the company has secured £5 million in equity finance...

Gemalto Pilots Biometric Boarding at Los Angeles International Airport

AMSTERDAM–(BUSINESS WIRE)– Gemalto (Euronext NL0000400653 GTO) announce a joint pilot with a leading airline to bring additional convenience and security to the traveler’s experience via...

Abzena Announces Expansion of Integrated Biologics Offering with the Addition of Preformulation and Formulation Capability

CAMBRIDGE, England–(BUSINESS WIRE)– Dr. Jonathan Goldman, CEO, Abzena, announced that Abzena has augmented existing discovery to GMP drug substance and Antibody Drug Conjugates (ADC) manufacturing...

Welch’s Leverages Rimini Street Support for its Oracle E-Business Suite and Oracle Database

LAS VEGAS–(BUSINESS WIRE)– Massachusetts–based maker of grape juice and jelly saves nearly $1 million in maintenance fees, invests in new applications and strategic initiatives Rimini...

Alipay Supports Growth Opportunities and Digital Innovation for Start-Ups in Malaysia

SHAH ALAM, Selangor–(BUSINESS WIRE)– As part of Alipay’s commitment to supporting digital innovation and talent cultivation in Southeast Asia, the Company today launched its Malaysia...

Exelixis and Ipsen Initiate Phase 3 Pivotal Trial (COSMIC-312) of Cabozantinib in Combination with Atezolizumab versus Sorafenib in Previously Untreated Advanced Hepatocellular Carcinoma

ALAMEDA, Calif. & PARIS–(BUSINESS WIRE)– – Clinical trial will also explore single-agent activity of cabozantinib in the first-line setting – Regulatory News: Exelixis, Inc. (Nasdaq: EXEL)...

Social Media Companies Believed to Be Vulnerable, with 61% of Consumers Saying They Pose Greatest Risk for Exposing Data, Finds Gemalto

AMSTERDAM–(BUSINESS WIRE)– A majority of consumers are willing to walk away from businesses entirely if they suffer a data breach, with retailers most at risk,...

IFF-LMC Strengthens Product Portfolio with Acquisition of Sustainable Ingredients

NEW YORK–(BUSINESS WIRE)– IFF-Lucas Meyer Cosmetics (IFF-LMC), a cosmetic actives subsidiary of International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) (TASE:IFF), has expanded and...

China’s National Medical Products Administration Approves Harvoni® (Ledipasvir/Sofosbuvir) for Treatment of Chronic Hepatitis C Virus Genotype 1-6

FOSTER CITY, Calif.–(BUSINESS WIRE)– –Harvoni Offers Highly Effective, Short-Duration, Pan-Genotypic Treatment for Chinese Patients with HCV Infection– –Harvoni Achieved Cure Rate (SVR12) of 100 Percent...

China National Medical Products Administration Approves Descovy® (Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection

FOSTER CITY, Calif.–(BUSINESS WIRE)– – Fixed-Dose Combination HIV Treatment Backbone Can Be Paired with Range of Third Agents – Gilead Sciences, Inc. (NASDAQ: GILD) today...

ABB enables groundbreaking trial of remotely operated passenger ferry

HELSINKI–(BUSINESS WIRE)– Ice-class passenger ferry Suomenlinna II was remotely piloted through test area near Helsinki harbor, proving that human oversight of vessels from anywhere is...

bluebird bio Presents New Data for LentiGlobin Gene Therapy in Transfusion Dependent β-Thalassemia at 60th Annual Meeting of the American Society of Hematology

CAMBRIDGE, Mass.–(BUSINESS WIRE)– First presentation of data from patients with a β0/β0 genotype and a pediatric patient treated with LentiGlobin in Phase 3 Northstar-3 study...

bluebird bio Presents New Data for LentiGlobin Gene Therapy in Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology

CAMBRIDGE, Mass.–(BUSINESS WIRE)– LentiGlobin treatment-derived hemoglobin HbAT87Q equals or exceeds sickling hemoglobin (HbS) levels in Group C patients at six months post treatment Total hemoglobin...

A CMI Solar Receiver Will Equip the World’s Tallest Solar Tower in Dubai

SERAING, Belgium–(BUSINESS WIRE)– CMI Energy awarded a contract for the Mohammed bin Rashid al Maktoum solar park in Dubai After its commercial success in China...

Kite Announces Updated Data From ZUMA-3 Study of KTE-X19 in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

SAN DIEGO–(BUSINESS WIRE)– — Ongoing Phase 1/2 Study Continues to Demonstrate High Rates of Response to a Single Infusion of KTE-X19 in a Patient Population...